A case of erythropoietic protoporphyria with liver cirrhosis suggesting a therapeutic value of supplementation with α-tocopherol

Hepatology Research

Volumn 18, Issue 3, 2000, Pages 298-309

  Komatsu, Hirokazu ^a   Ishii, Kohdoh ^b   Imamura, Kiyoko ^a   Maruyama, Katsuya ^c   Yonei, Yoshikazu ^d   Masuda, Hideaki ^a   Tsuchihashi, Takeshi ^a   Sajima, Yoshikiyo ^a  

^a YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^b Yokohama National University   (Japan)

^c KURIHAMA NATIONAL HOSPITAL   (Japan)

^d Nihon Kokan Hospital   (Japan)

Author keywords

Tocopherol; Erythropoietic protoporphyria; Liver cirrhosis

Indexed keywords

ALPHA TOCOPHEROL; ERYTHROCYTE PROTOPORPHYRIN; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CASE REPORT; COLOR; DRUG EFFECT; ELECTRON MICROSCOPY; ERYTHROCYTE COUNT; ERYTHROPOIETIC PROTOPORPHYRIA; FOLLOW UP; HISTIOCYTE; HUMAN; INTRAHEPATIC BILE DUCT; KUPFFER CELL; LIVER BIOPSY; LIVER CELL; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MALE; PERCUTANEOUS BIOPSY; PIGMENTATION; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 0033814744     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00077-2     Document Type: Article

References (35)

1. Erythropoietic protoporphyria: A new porphyria syndrome with solar urticaria due to protoporphyrinemia
2. Congenital erythropoietic protoporphyria. I: Case reports, clinical studies and porphyrin analyses in two brothers
3. Chenodeoxycholic acid therapy in erythrohepatic protoporphyria
4. Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment
5. Photoprotection in erythropoietic protoporhyria: Mechanism of photo-protection by beta carotene
6. β-carotene serum levels in patients with erythropoietic protoporphyria on treatment with the synthetic all-trans isomer or a natural isomeric mixture of β-carotene
7. Effect of hematin administration to patients with protoporphyria and liver disease
8. Hematin therapy in children with protoporphyric liver disease
9. Pathogenesis and therapy of liver disease in protoporphyria
10. Blood exchange and transfusion therapy for acute cholestasis in protoporphyria
11. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria
12. Liver transplantation in a patient with protoporphyria
13. Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy
14. Hepatic failure and death from erythropoietic protoporphyria
15. A light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice
16. The liver in protoporphyria
17. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver
18. Erythropoietic protoporphyria: Evidence for multiple sites of excess protoporphyrin formation
19. Isotopic studies of the erythropoietic and hepatic components of congenital porphyria and erythropoietic protoporphyria
20. Erythropoietic protoporphyria: 10 years experience
21. Hepatobiliary changes in erythropoietic protoporphyria
22. Erythropoietic porphyrin hepatitis
23. Erythropoietic protoporphyria: Two deaths from hepatic cirrhosis
24. Hepatic disease in erythropoietic protoporphyria
25. The influence of porphyrins on iron-catalyzed generation of hydroxyl radicals
26. Conversion of light to chemical free energy. I: Porphyrin-sensitized photoreduction of ferredoxin by glutathione
27. Free radicals from photoreduction of hematoporphyrin in aqueous solution
28. The one-electron reduction of uroporphyrin I by rat hepatic microsomes
29. Release of reactive oxygen by hepatocytes on reoxygenation: Three phases and role of mitochondria
30. Oxidative stress in the liver and biliary tract diseases
31. Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria
32. The 'glucose effect' in erythropoietic protoporphyria
33. Mechanism causing vitamin E deficiency during chronic childhood cholestasis
34. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: A randomized, double-blind, placebo-controlled study
35. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat